why choose us

First received: December 25, 2024

Clinical Trial: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Seasonal Allergic Rhinitis

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of TQH2722 Injection Combined With Background Therapy in Patients With Seasonal

Brief Summary: To evaluate TQH2722 injection in all patients receiving background treatment with mometasone furoate nasal spray (MFNS) and loratadine.The efficacy, safety and immunogenicity of the solution in patients with seasonal allergic rhinitis compared with placebo are expected to include 168 patients with confirmed seasonal allergic rhinitis (SAR) who have failed to respond to standard treatments.

Read more